Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention

被引：96

作者：

Vivekananthan, DP

Bhatt, DL

Chew, DP

Zidar, FJ

Chan, AW

Moliterno, DJ

Ellis, SG

Topol, EJ

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25, Cleveland, OH 44195 USA

[2] Flinders Med Ctr, Adelaide, SA, Australia

[3] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 03期

关键词：

D O I：

10.1016/j.amjcard.2004.04.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study sought to determine the effect of clopidogrel pretreatment on the increase in C-reactive protein (CRP) after percutaneous coronary intervention. Clopidogrel pretreatment attenuated the periprocedural increase in CRP by 65% and was independently associated with an attenuation in the CRP increase in a multivariate model. (C) 2004 by Excerpto Medica, Inc.

引用

页码：358 / 360

页数：3

共 19 条

[1] Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
Assali, AR
Salloum, J
Sdringola, S
Moustapha, A
Ghani, M
Hale, S
Schroth, G
Fujise, K
Anderson, HV
Smalling, RW
Rosales, OR
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (08) : 884 - +
[2] Berglund Ulf, 2002, J Invasive Cardiol, V14, P243
[3] Scientific and therapeutic advances in antiplatelet therapy
Bhatt, DL
Topol, EJ
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) : 15 - 28
[4] Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival - Results from the do tirofiban and ReoPro give similar efficacy outcome trial (TARGET)
Chan, AW
Moliterno, DJ
Berger, PB
Stone, GW
DiBattiste, PM
Yakubov, SL
Sapp, SK
Wolski, K
Bhatt, DL
Topol, EJ
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) : 1188 - 1195
[5] Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein
Chew, DP
Bhatt, DL
Robbins, MA
Mukherjee, D
Roffi, M
Schneider, JP
Topol, EJ
Ellis, SG
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) : 672 - 674
[6] INTRAMYOCARDIAL PLATELET-AGGREGATION IN PATIENTS WITH UNSTABLE ANGINA SUFFERING SUDDEN ISCHEMIC CARDIAC DEATH
DAVIES, MJ
THOMAS, AC
KNAPMAN, PA
HANGARTNER, JR
[J]. CIRCULATION, 1986, 73 (03) : 418 - 427
[7] FRINK RJ, 1988, BRIT HEART J, V59, P196
[8] Soluble CD40 ligand in acute coronary syndromes
Heeschen, C
Dimmeler, S
Hamm, CW
van den Brand, MJ
Boersma, E
Zeiher, AM
Simoons, ML
CAPTURE Study Investigators
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) : 1104 - 1111
[9] CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V
Slupsky, JR
Gräfe, M
Anagnostopoulos, I
Förster, R
Müller-Berghaus, G
Kroczek, RA
[J]. NATURE, 1998, 391 (6667) : 591 - 594
[10] Platelet CD40 ligand (CD40L) -: subcellular localization, regulation of expression, and inhibition by clopidogrel
Hermann, A
Rauch, BH
Braun, M
Schrör, K
Weber, AA
[J]. PLATELETS, 2001, 12 (02) : 74 - 82

← 1 2 →